Cardlytics (CDLX) Expected to Release Quarterly Earnings on Wednesday

Cardlytics (NASDAQ:CDLXGet Free Report) is expected to be announcing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Cardlytics to post earnings of ($2.30) per share and revenue of $37.0030 million for the quarter. Individuals can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:00 PM ET.

Cardlytics Stock Up 2.7%

Shares of Cardlytics stock opened at $3.84 on Wednesday. The stock has a market cap of $22.31 million, a PE ratio of -0.22 and a beta of 0.61. The business has a fifty day simple moving average of $5.15 and a 200-day simple moving average of $7.87. Cardlytics has a 12 month low of $3.50 and a 12 month high of $32.80.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research note on Thursday, June 18th. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, June 13th. Lake Street Capital set a $10.00 price target on shares of Cardlytics in a research report on Friday, May 8th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. Two analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $10.00.

Check Out Our Latest Report on CDLX

Insiders Place Their Bets

In related news, CEO Amit Gupta sold 9,640 shares of Cardlytics stock in a transaction on Monday, July 6th. The stock was sold at an average price of $4.39, for a total transaction of $42,319.60. Following the completion of the sale, the chief executive officer owned 113,850 shares of the company’s stock, valued at approximately $499,801.50. This trade represents a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO David Thomas Evans bought 15,000 shares of the stock in a transaction on Friday, May 15th. The stock was purchased at an average price of $6.50 per share, for a total transaction of $97,500.00. Following the purchase, the chief financial officer directly owned 26,793 shares of the company’s stock, valued at approximately $174,154.50. This represents a 127.19% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders sold 18,289 shares of company stock worth $80,289 over the last ninety days. 5.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cardlytics

Several institutional investors have recently made changes to their positions in CDLX. Qube Research & Technologies Ltd bought a new stake in shares of Cardlytics in the 3rd quarter valued at approximately $55,000. Boothbay Fund Management LLC acquired a new position in Cardlytics in the third quarter worth approximately $74,000. Virtu Financial LLC bought a new position in Cardlytics during the fourth quarter valued at approximately $39,000. Marshall Wace LLP bought a new position in Cardlytics during the second quarter valued at approximately $59,000. Finally, Lighthouse Investment Partners LLC acquired a new stake in Cardlytics in the third quarter valued at approximately $89,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Further Reading

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.